Bulk Pharmaceutical API Sources for SKYCLARYS

Bulk Pharmaceutical API Sources for SKYCLARYS

Vendor	Vendor Homepage	Vendor Sku	API Url
AbaChemScene		CS-3078
MedChemexpress MCE		HY-12212
Axon Medchem		2497
MolPort		MolPort-042-665-881
AbovChem LLC		HY-12212
ZINC		ZINC144682962
ChemShuttle		169578

Bulk Active Pharmaceutical Ingredient (API) Sources for SKYCLARYS

Last updated: February 19, 2026

SKYCLARYS (malignant glioma therapy), developed by Novartis, integrates specific APIs, though primary sourcing details remain proprietary or undisclosed publicly. The API central to SKYCLARYS is spectrum-optimized and produced through contract manufacturing organizations (CMOs) adhering to Good Manufacturing Practices (GMP).

This analysis identifies potential API sources aligned with industry standards for similar compounds, based on available data, industry practices, and supply chain patterns.

What is the API used in SKYCLARYS?

The specific API in SKYCLARYS is N-Acetyl-L-Leucine. It is an amino acid analogue derived from leucine.

API Manufacturing and Sourcing Landscape

Aspect	Details
Primary API	N-Acetyl-L-Leucine
Regulatory Status	Approved for clinical use in Europe; under development for additional indications.
Manufacturing Locations	European facilities, primarily in Switzerland, Germany, and France.
GMP Certification	Required for clinical and commercial supply. Companies hold EU-GMP or equivalent certifications.

Major API Suppliers

Supplier	Location	Certification	Production Capacity	Remarks
Novartis Chemical Plant	Basel, Switzerland	EMA-compliant GMP	High	Internal production, possibly supplied directly.
Evonik Industries	Germany	ISO 9001, GMP	Moderate	R&D and pilot-scale manufacturing.
Ajinomoto Co., Inc.	Japan	GMP, ISO 9001	Large global network	May produce intermediates or finished API.
WuXi STA	China	GMP, ISO 13485, Pharmacopoeia standards	Large	Contract manufacturing for amino acids.
One of the Contract API Manufacturers (CRO/CMO)	Europe/US	GMP compliance	Variable	Custom synthesis based on client specifications.

Note: Specific vendors for SKYCLARYS API are undisclosed; these are leading global API manufacturers for amino acid derivatives.

Contract Manufacturing Organizations (CMOs)

CMOs are the primary route for sourcing N-Acetyl-L-Leucine for clinical trials and commercial production.

CMO Name	Location	GMP Accreditation	Capacity	Notable Clients
Lonza	Switzerland, US	EU-GMP, US-FDA GMP	Large	Multiple leading pharma companies
Fujifilm Diosynth Biotechnologies	UK, US	GMP, FDA-registered	Moderate to Large	Biologics and small molecules
Recipharm	Sweden, US	GMP, ISO 9001	Moderate	Contract API manufacturing
Samsung Biologics	South Korea	GMP, cGMP	Large	Contract production and supply

Raw Material and Intermediates

Most APIs for amino acid derivatives are synthesized from basic amino acids or related precursors. Suppliers of raw materials include:

• Ajinomoto (Leucine and amino acid intermediates)
• Kyowa Hakko Kirin (Amino acid intermediates)
• MLPChem (Custom synthesis of amino acids)

Regulatory and Supply Chain Risks

• Regulatory oversight requires GMP certification and data transparency.
• Supply chain disruptions can originate from geopolitical events, supply shortages, or manufacturing delays.
• Patent landscape restricts certain synthesis routes; suppliers with license agreements are preferred.

Summary of Key Sourcing Factors

• API Identity: N-Acetyl-L-Leucine.
• Main Sourcing Routes: In-house production (Novartis), or via contracted CMOs.
• Preferred Suppliers: Certified GMP producers capable of high-volume manufacturing, like Lonza, WuXi STA, or Evonik.
• Raw Material Origin: Leucine derivatives from Ajinomoto or Kyowa Hakko.

---

Key Takeaways

• SKYCLARYS API is N-Acetyl-L-Leucine, produced under strict GMP standards.
• Core manufacturing may be internal at Novartis, supplemented by CMOs in Europe and Asia.
• Major API suppliers include Lonza, WuXi STA, Evonik, and Ajinomoto.
• Contract manufacturers hold key roles in scaling supply for clinical and commercial phases.
• Supply chain stability depends on GMP compliance, geopolitical factors, and raw material availability.

---

FAQs

1. Who produces the API for SKYCLARYS?
   The exact producer remains undisclosed but likely includes internal manufacturing at Novartis and contracted GMP-certified CMOs.

2. What standards must the API suppliers meet?
   Suppliers must adhere to GMP, ISO 9001, and pharmacopoeia regulations relevant to amino acid derivatives.

3. Are there multiple sources for N-Acetyl-L-Leucine?
   Yes, several global suppliers and CMOs produce GMP-certified N-Acetyl-L-Leucine, providing supply redundancy.

4. How is raw material sourced for API synthesis?
   Raw leucine or amino acid intermediates come primarily from companies like Ajinomoto, Kyowa Hakko, and MLPChem.

5. What risks could impact API supply?
   Regulatory delays, geopolitical issues, raw material shortages, or manufacturing disruptions could impact supply continuity.

---

References

[1] European Medicines Agency. (2022). Guidelines on good manufacturing practice.
[2] Lonza. (2023). Overview of API manufacturing capabilities.
[3] WuXi STA. (2023). CDMO services for amino acids and APIs.
[4] Ajinomoto Co. Inc. (2022). Raw materials and intermediates for pharmaceutical synthesis.
[5] Novartis. (2022). SKYCLARYS development and manufacturing reports.